Kazakhstan´s Experience on Biosafety & Biosecurity trainings in the Framework of EU CBRN CoE Project 53 presented at the 16th Medical Biodefense Conference, Munich, Germany

A team of Kazakh experts from EU CBRN CoE Project 53 presented the activities and results of this initiative at the high profile 16th Medical Biodefense Conference, conducted in Munich, Germany last 28 to 31 October 2018.

Prof. Andrey DMITROVSKIY provided the Project 53 accomplishments in a presentation that was received with great interest, and which motivated numerous questions and recognition from the international audience. An abstract about EU CBRN CoE Project 53 was published in the proceedings of the Medical Biodefense Conference. The abstract was authored cooperatively by representatives of the Kazakh P53 National Team of Experts and the EU Team of Experts.

As part of the Project 53 of the European Union Chemical Biological Radiological and Nuclear Risk Mitigation Centers of Excellence Initiative (EU CBRN CoE) (, Kazakhstan conducted an institutional and laboratory education needs assessment in 2017. Based on this assessment a sustainable Biosafety & Biosecurity (BS&S) training program was developed. Initially, 14 Kazakh experts were trained to be trainers by the EU Team of Experts in Biosafety (Public Health England) and Biosecurity (RIVM) with support from Kazakh experts. Kazakh trainees came from 7 universities (4 medical, 2 biological, 1 agricultural/veterinary), 4 national centers (2 medical, 1 biological, 1 veterinary) and the Uralsk Anti Plague station to maximize the range of institutes that the new trainers could reach.

Currently, 6 BS&S training centers have been established in Almaty (4 newly trained trainers), Astana (3), Karaganda (1), Semipalatinsk (1), Shymkent (1) and Uralsk (1). Additionally, BS&S courses were successfully developed for their inclusion in the compulsory curriculum of medical, veterinary and biological students of the next (2018-2019) academic year.

The 16th Medical Biodefense Conference is a unique international event, organized by the Bundeswehr Institute of Microbiology, at the Bundeswehr Medical Academy in Munich. Global interest in this high-profile Conference, which focuses on the medical aspects of biodefense, has been steadily growing. It provides a platform to share information in the areas of diagnostics, treatment and prevention of diseases caused by highly dangerous infectious agents.